PropertyValue
?:definition
  • Clinical chemistry reagents intended to be used in the performance of qualitative and/or quantitative chemical analyses of body fluids (e.g., serum, plasma) to determine the level of the enzyme adenosine deaminase (ADA) produced following instruction given by the ADA genes. Low ADA levels in blood are related to systemic metabolic disorders; ADA deficiency may cause opportunistic infections associated with marked lymphocytopenia and the absence of both humoral and cellular immune function. Early onset of ADA deficiency, usually diagnosed before age six months, characterizes a disease known as severe combined immunodeficiency disease (SCID).
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C3504168_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C3504168_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all